METTL3 and lung carcinoma: In a murine cisplatin-resistant lung cancer model, METTL3 upregulates YAP expression to promote drug resistance and metastasis by YTHDF1/3, eIF3b and the MALAT1-miR-1914-3p-YAP axis [38].